Cargando…
Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana
BACKGROUND: Guyana is one of four countries in the Latin American Region where lymphatic filariasis (LF) remains endemic. In preparation for the introduction of a new triple drug therapy regimen (ivermectin, diethylcarbamazine, and albendazole (IDA)) in 2019, an acceptability study was embedded with...
Autores principales: | Niles, Reza A., Thickstun, Charles R., Cox, Horace, Dilliott, Daniel, Burgert-Brucker, Clara R., Harding-Esch, Emma M., Clementson, Nikita, Sampson, Annastacia, Alexandre, Jean Seme, Morice Trejos, Ana C., Scholte, Ronaldo G. Carvalho, Krentel, Alison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452018/ https://www.ncbi.nlm.nih.gov/pubmed/34543269 http://dx.doi.org/10.1371/journal.pntd.0009596 |
Ejemplares similares
-
Progress towards elimination of lymphatic filariasis in the Americas region
por: Fontes, Gilberto, et al.
Publicado: (2020) -
A mixed-methods exploration into the resilience of community drug distributors conducting mass drug administration for preventive chemotherapy of lymphatic filariasis and onchocerciasis in Côte d’Ivoire and Uganda
por: Dilliott, Daniel, et al.
Publicado: (2022) -
Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis
por: Krentel, Alison, et al.
Publicado: (2020) -
Modernizing the design and analysis of prevalence surveys for neglected tropical diseases
por: Diggle, Peter J, et al.
Publicado: (2023) -
A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
por: Krentel, Alison, et al.
Publicado: (2013)